1 |
Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus |
|
| | Alan R. Berger, Alan F. Cruess, Filiberto Altomare, Varun Chaudhary, Kevin Colleaux, Mark Greve, Amin Kherani, Efrem D. Mandelcorn, Hugh Parsons, Marc-André Rhéaume, Eric Tourville | | | Ophthalmologica. 2015; 234(1): 6 | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab |
|
| | SeulGi Yoo, JaeHui Kim, TaeGon Lee, ChulGu Kim, JongWoo Kim | | | Indian Journal of Ophthalmology. 2015; 63(1): 25 | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
Meta-Analysis of the Effect of Intravitreal Bevacizumab Versus Intravitreal Triamcinolone Acetonide in Central Retinal Vein Occlusion |
|
| | Zi Ye Jin,Dan Zhu,Yong Tao,Ian Y. Wong,Jost B. Jonas | | | Journal of Ocular Pharmacology and Therapeutics. 2013; 29(9): 826 | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
Intravitreal Triamcinolone Acetonide Compared With Bevacizumab for the Treatment of Patients With Macular Edema Secondary to Central Retinal Vein Occlusion |
|
| | Gokcen Gokce,Gungor Sobaci,Ali Hakan Durukan,Fazil Cuneyt Erdurman | | | Postgraduate Medicine. 2013; 125(5): 51 | | | [Pubmed] [Google Scholar] [DOI] | |
|